Tuniyazi Maimaiti, Hu Xiaoyu, Fu Yunhe, Zhang Naisheng
College of Veterinary Medicine, Jilin University, Changchun 130062, China.
Vet Sci. 2022 Jul 30;9(8):396. doi: 10.3390/vetsci9080396.
Fecal microbiota transplantation (FMT) is an emerging therapeutic option for a variety of diseases, and is characterized as the transfer of fecal microorganisms from a healthy donor into the intestinal tract of a diseased recipient. In human clinics, FMT has been used for treating diseases for decades, with promising results. In recent years, veterinary specialists adapted FMT in canine patients; however, compared to humans, canine FMT is more inclined towards research purposes than practical applications in most cases, due to safety concerns. Therefore, in order to facilitate the application of fecal transplant therapy in dogs, in this paper, we review recent applications of FMT in canine clinical treatments, as well as possible mechanisms that are involved in the process of the therapeutic effect of FMT. More research is needed to explore more effective and safer approaches for conducting FMT in dogs.
粪便微生物群移植(FMT)是治疗多种疾病的一种新兴疗法,其特点是将健康供体的粪便微生物转移到患病受体的肠道中。在人类临床中,FMT已用于治疗疾病数十年,效果良好。近年来,兽医专家将FMT应用于犬类患者;然而,与人类相比,由于安全问题,在大多数情况下,犬类FMT更倾向于研究目的而非实际应用。因此,为了促进粪便移植疗法在犬类中的应用,本文综述了FMT在犬类临床治疗中的最新应用,以及FMT治疗效果过程中可能涉及的机制。需要更多的研究来探索在犬类中进行FMT更有效、更安全的方法。